VIR-2482 (450 mg)
VIR-2482-4002
Phase 2 mab terminated
Quick answer
VIR-2482 (450 mg) for Influenza A is a Phase 2 program (mab) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vir Biotechnology
- Indication
- Influenza A
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated